← Back to directory
TR
Third Rock Ventures
Boston, MassachusettsWebsite ↗
Third Rock Ventures is a leading healthcare venture capital firm dedicated to discovering, launching, and building transformative life science companies. The firm employs a hands-on approach, actively shaping company formation from inception to translate scientific innovations into breakthrough medicines for patients.
Last raised
Jun 2022
4y 3mo ago
Latest fund size
$1.1B
Third Rock Ventures Fund VI
AUM
$3.8B
estimated
Funds raised
Capital this firm has raised, newest first
Third Rock Ventures Fund VI
Jun 2022 · Fund VI
$1.1B
Third Rock Ventures Fund V
Jun 2019 · Fund V
$770M
Third Rock Ventures Fund IV
Oct 2016 · Fund IV
$616M
Third Rock Ventures Fund III
Jan 2013 · Fund III
$516M
Third Rock Ventures Fund II
Sep 2010 · Fund II
$426M
Third Rock Ventures Fund I
Jan 2007 · Fund I
$378M
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Flare TherapeuticsLead | — | $85M | Jun 2026 | source ↗ |
| Terremoto Biosciences | — | $108M | Apr 2026 | source ↗ |
| Syremis TherapeuticsLead | Series A | $165M | Dec 2025 | source ↗ |
| Azalea TherapeuticsLead | Series A | $82M | Nov 2025 | source ↗ |
| ARTBIO | Series B | $132M | Jul 2025 | source ↗ |
| Corvia Medical | — | $55M | Jun 2025 | source ↗ |
| Maze Therapeutics | — | $115M | Nov 2024 | source ↗ |
| Seaport Therapeutics | Series B | $225M | Nov 2024 | source ↗ |
Sources
Where this data came from